Is stem cell therapy for Chronic Kidney Disease worth it?
Outside an authorised study, current evidence does not support paying for a regenerative product as established CKD treatment. Independent nephrology review should compare the exact protocol with proven risk-factor control, medicines and timely kidney-replacement planning.
How stem cells are studied for Chronic Kidney Disease
Chronic kidney disease (CKD) is persistent kidney damage or reduced filtration caused by diabetes, hypertension, immune, genetic, obstructive and other disorders. Cell and exosome research explores inflammatory, vascular and repair mechanisms, but a laboratory signal does not establish restored nephron number, delayed kidney failure or avoidance of dialysis or transplantation.
Am I a candidate? → · Chronic Kidney Disease: full overview → · Chronic Kidney Disease cost → · Cost →
Evidence checked against ISSCR, FDA and EMA guidance. See our editorial standards. This is information, not medical advice. Educational information, not medical advice; figures indicative.
Sources & further reading
More on this condition
- Chronic Kidney Disease: cell-therapy evidence and registered trials
- How much does stem cell therapy for Chronic Kidney Disease cost? (2026)
- Chronic Kidney Disease stem cell therapy — your questions answered (2026)
- Chronic Kidney Disease: cell-therapy evidence by therapy class
- MSC vs HSCT for Chronic Kidney Disease: what the registries show